Follow
Amir Landi, MD PhD
Amir Landi, MD PhD
Verified email at ualberta.ca
Title
Cited by
Cited by
Year
The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody-and cell-mediated immune responses in mice
J Kovacs-Nolan, L Latimer, A Landi, H Jenssen, REW Hancock, ...
Vaccine 27 (14), 2055-2064, 2009
89*2009
High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer
A Landi, LA Babiuk, S van Drunen Littel-van den Hurk
J Leukoc Biol 82 (4), 849-860, 2007
75*2007
Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis
A Landi, TJ Weismuller, TO Lankisch, DM Santer, DLJ Tyrrell, MP Manns, ...
Journal of Interferon & Cytokine Research 34 (3), 204-214, 2014
602014
Dendritic cells matured by a prostaglandin E2-containing cocktail can produce high levels of IL-12p70 and are more mature and Th1-biased than dendritic cells treated with TNF-α …
A Landi, LA Babiuk
Immunobiology 216 (6), 649-662, 2011
47*2011
Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome
A Landi, D Broadhurst, SD Vernon, DLJ Tyrrell, M Houghton
Cytokine 78, 27-36, 2016
462016
Progress towards a hepatitis C virus vaccine
L Man John Law, A Landi, WC Magee, D Lorne Tyrrell, M Houghton
Emerging microbes & infections 2 (1), 1-7, 2013
462013
DNA prime–protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge
R Liang, JV Van den Hurk, A Landi, Z Lawman, D Deregt, H Townsend, ...
Journal of General Virology 89 (2), 453-466, 2008
452008
Enhanced activation of memory, but not naive, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis
DM Santer, MM Ma, D Hockman, A Landi, DLJ Tyrrell, M Houghton
PloS one 8 (6), e68308, 2013
442013
Role of the E2 hypervariable region (HVR1) in the immunogenicity of a recombinant hepatitis C virus vaccine
JLM Law, M Logan, J Wong, J Kundu, D Hockman, A Landi, C Chen, ...
Journal of Virology 92 (11), e02141-17, 2018
352018
Native folding of a recombinant gpE1/gpE2 heterodimer vaccine antigen from a precursor protein fused with Fc IgG
M Logan, J Law, JAJX Wong, D Hockman, A Landi, C Chen, K Crawford, ...
Journal of virology 91 (1), e01552-16, 2017
342017
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
A Landi, J Law, D Hockman, M Logan, K Crawford, C Chen, J Kundu, ...
Vaccine 35 (50), 6949-6956, 2017
292017
Indolamine 2, 3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients
S Schulz, A Landi, R Garg, JA Wilson, S van Drunen Littel-van den Hurk
Clinical & Experimental Immunology 180 (3), 484-498, 2015
292015
Effect of different adjuvants on the longevity and strength of humoral and cellular immune responses to the HCV envelope glycoproteins
B Akache, L Deschatelets, BA Harrison, R Dudani, FC Stark, Y Jia, ...
Vaccines 7 (4), 204, 2019
282019
No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome
I Steffen, DL Tyrrell, E Stein, L Montalvo, TH Lee, Y Zhou, K Lu, ...
PloS one 6 (11), e27870, 2011
252011
SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1
JLM Law, M Logan, MA Joyce, A Landi, D Hockman, K Crawford, ...
Vaccine 39 (40), 5769-5779, 2021
182021
Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation
A Landi, H Yu, LA Babiuk, S van Drunen Littel‐van den Hurk
Journal of Viral Hepatitis 18 (10), 700-713, 2011
14*2011
Investigation of the level of IgG, IgM and IgA antibodies against A60 antigen in tuberculosis patients referred to PHLS, Ahvaz, Iran
AD Khosravi, R Torabizadeh, A Landi
Pakistan Journal of Meical sciences 21 (4), 465-469, 2005
102005
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
Y Gindin, C Chung, Z Jiang, JZ Zhou, J Xu, AN Billin, RP Myers, ...
Hepatology 73 (3), 1105-1116, 2021
62021
Virological footprint of T-Cell responses in patients with primary biliary cirrhosis
M Rahbari, D Sharon, A Landi, M Houghton, A Mason
Canadian Journal of Gastroenterology and Hepatology 29, 159A, 2015
52015
The compound (3-{5-[(2, 5-dimethoxyphenyl) amino]-1, 3, 4-thiadiazolidin-2-yl}-5, 8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrPC to PrPSc with …
NS Pagadala, TC Bjorndahl, M Joyce, DS Wishart, K Syed, A Landi
Bioorganic & Medicinal Chemistry 25 (20), 5875-5888, 2017
42017
The system can't perform the operation now. Try again later.
Articles 1–20